Average Co-Inventor Count = 5.55
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abclon Inc. (5 from 9 patents)
2. Gc Cell Corporation (4 from 8 patents)
9 patents:
1. 12410261 - Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
2. 12116417 - Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
3. 12090171 - Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
4. 11970547 - Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
5. 11708409 - Antibody or antigen-binding fragment thereof that specifically recognizes B cell malignancies, chimeric antigen receptor comprising same, and uses thereof
6. 11649294 - Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
7. 11534462 - Antibody or antigen binding fragment thereof for specifically recognizing B cell malignancy, chimeric antigen receptor comprising same and use thereof
8. 11248059 - Antibody having improved stability and specifically binding to HER2
9. 10465008 - Antibodies against vascular endothelial growth factor receptor 2 (VEGFR2), encoding nucleic acid molecules and methods for treating an angiogenesis-related disease